Rationale for the short-term use of luteinising hormone-releasing hormone analogues in the treatment of uterine myomata.
Luteinising hormone-releasing hormone (LHRH) analogue administration can reduce the size of uterine leiomyomata and its pre-operative use prior to myomectomy or hysterectomy is discussed. It is concluded that pre-operative use of LHRH analogues does have a role in gynaecological surgery.
Stovall
T G
TG
Department of Obstetrics and Gynecology, University of Tennessee, Memphis.
D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives*; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy* / Q000601:surgery; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000601:surgery
D007987:Gonadotropin-Releasing Hormone